Who owns ANEBULO PHARMACEUTICALS INC?
- Ticker: ANEB
- CUSIP Number: 034569103
Tip: Access positions for across all investors
Analyze quarterly positions in Anebulo Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Anebulo Pharmaceuticals stock
Who bought or sold ANEBULO PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| 22NW | 16M | $85M | 0% | Dec 2025 |
|
| Nantahala Capital Management | 3.0M | $3.1M | 0% | Dec 2025 |
|
| Mangrove Partners | 2.5M | $2.6M | 0% | Dec 2025 |
|
| Vanguard Group | 436k | $440k | 42% | Dec 2025 |
|
| Geode Capital Management | 161k | $163k | -8% | Dec 2025 |
|
| Rangeley Capital | 50k | $51k | 150% | Dec 2025 |
|
| Renaissance Technologies | 25k | $25k | -12% | Dec 2025 |
|
| BlackRock | 24k | $24k | -1% | Dec 2025 |
|
| Northern Trust | 22k | $22k | -10% | Dec 2025 |
|
| Ikarian Capital | 18k | $18k | -89% | Dec 2025 |
|
| State Street Corporation | 13k | $13k | 0% | Dec 2025 |
|
| Tower Research Capital | 3.2k | $3.3k | 85% | Dec 2025 |
|
| UBS Group | 2.3k | $2.4k | 961% | Dec 2025 |
|
| Jpmorgan Chase & Co | 2.1k | $5.3k | 100% | Sep 2025 |
|
| FNY Investment Advisers | 100.00 | $0 | 5% | Dec 2025 |
|
Who sold out of Anebulo Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Jun 2025 | 154k | $222k |
| Citadel Advisors | Jun 2025 | 25k | $36k |
| XTX Topco | Sep 2025 | 19k | $48k |
| Boothbay Fund Management | Sep 2025 | 19k | $47k |
| Barclays | Sep 2025 | 399.00 | $998.018700 |